These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 20113832)
41. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related]
42. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Ye M; Li D; Zhou F; Guo Q; Xia B Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297 [TBL] [Abstract][Full Text] [Related]
43. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052 [TBL] [Abstract][Full Text] [Related]
44. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872 [TBL] [Abstract][Full Text] [Related]
45. Promoter methylation of cyclin D2 gene in gastric carcinoma. Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939 [TBL] [Abstract][Full Text] [Related]
46. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664 [TBL] [Abstract][Full Text] [Related]
48. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600 [TBL] [Abstract][Full Text] [Related]
49. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer. Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852 [TBL] [Abstract][Full Text] [Related]
50. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
51. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer. Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394 [TBL] [Abstract][Full Text] [Related]
52. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. Jee CD; Kim MA; Jung EJ; Kim J; Kim WH Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878 [TBL] [Abstract][Full Text] [Related]
53. Epigenetic silencing of BTB and CNC homology 2 and concerted promoter CpG methylation in gastric cancer. Haam K; Kim HJ; Lee KT; Kim JH; Kim M; Kim SY; Noh SM; Song KS; Kim YS Cancer Lett; 2014 Sep; 351(2):206-14. PubMed ID: 24858026 [TBL] [Abstract][Full Text] [Related]
54. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect. Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052 [TBL] [Abstract][Full Text] [Related]
55. Detection of TFPI2 methylation in the serum of gastric cancer patients. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206 [TBL] [Abstract][Full Text] [Related]
56. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens. Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645 [TBL] [Abstract][Full Text] [Related]
57. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis. Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734 [TBL] [Abstract][Full Text] [Related]
58. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684 [TBL] [Abstract][Full Text] [Related]
59. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292 [TBL] [Abstract][Full Text] [Related]
60. Aberrant hypermethylation of the FGFR2 gene in human gastric cancer cell lines. Park S; Kim JH; Jang JH Biochem Biophys Res Commun; 2007 Jun; 357(4):1011-5. PubMed ID: 17459342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]